Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · Real-Time Price · USD

Compare

14.09

-0.22 (-1.54%)

At close: Feb 11, 2026, 4:00 PM EST

14.20

+0.11 (0.78%)

After-hours: Feb 11, 2026, 5:56 PM EST

Seres Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	47.64	30.79	127.97	163.03	180	116.05
Short-Term Investments	-	-	-	18.31	110.7	137.57
Cash & Short-Term Investments	47.64	30.79	127.97	181.34	290.71	253.62
Cash Growth	-28.71%	-75.94%	-29.43%	-37.62%	14.62%	167.48%
Receivables	0.83	2.07	-	-	-	9.39
Prepaid Expenses	3.06	5.81	8.05	13.42	12.92	5.77
Other Current Assets	-	-	39.4	-	-	-
Total Current Assets	51.53	38.67	175.41	194.76	303.63	268.78
Property, Plant & Equipment	83.25	92.44	108.03	133.97	36.15	22.94
Long-Term Investments	-	-	-	-	0.5	49.83
Other Long-Term Assets	8.7	8.7	75.16	20.05	14.59	1.4
Total Assets	143.47	139.81	358.6	348.78	354.86	342.94
Accounts Payable	1.68	4.08	3.64	17.44	13.74	4.02
Accrued Expenses	6.38	10.72	22.51	25.07	24	14.23
Current Portion of Long-Term Debt	-	-	-	0.46	-	0.45
Current Portion of Leases	9.92	8.67	5.59	3.6	6.61	5.12
Current Unearned Revenue	-	-	-	4.26	16.82	22.6
Other Current Liabilities	4.45	17.75	66.92	34.77	21.1	-
Total Current Liabilities	22.43	41.22	98.66	85.6	82.26	46.42
Long-Term Debt	-	-	101.54	50.59	24.64	24.64
Long-Term Leases	75.33	82.97	91.65	107.94	17.96	10.56
Long-Term Unearned Revenue	-	-	-	92.43	87	85.57
Other Long-Term Liabilities	2.01	1.84	111.6	1.44	11.5	1
Total Liabilities	99.78	126.03	403.46	338	223.35	168.19
Common Stock	0.01	0.17	0.14	0.13	0.09	0.09
Additional Paid-In Capital	1,001	991.71	933.24	875.18	745.83	723.48
Retained Earnings	-957.07	-978.1	-978.24	-864.51	-614.35	-548.78
Comprehensive Income & Other	-	-	-	-0.01	-0.06	-0.05
Total Common Equity	43.7	13.78	-44.86	10.78	131.51	174.75
Shareholders' Equity	43.7	13.78	-44.86	10.78	131.51	174.75
Total Liabilities & Equity	143.47	139.81	358.6	348.78	354.86	342.94
Total Debt	85.25	91.64	198.78	162.59	49.21	40.77
Net Cash (Debt)	-37.62	-60.85	-70.82	18.75	241.5	212.85
Net Cash Growth	-	-	-	-92.23%	13.46%	325.39%
Net Cash Per Share	-4.32	-7.83	-11.07	3.47	52.67	53.35
Filing Date Shares Outstanding	9.05	8.72	7.55	6.3	4.6	4.58
Total Common Shares Outstanding	8.76	8.65	6.75	6.26	4.59	4.57
Working Capital	29.1	-2.55	76.75	109.17	221.37	222.36
Book Value Per Share	4.99	1.59	-6.64	1.72	28.62	38.21
Tangible Book Value	43.7	13.78	-44.86	10.78	131.51	174.75
Tangible Book Value Per Share	4.99	1.59	-6.64	1.72	28.62	38.21
Machinery	33.14	32.92	33.09	31.58	23.61	19.89
Construction In Progress	0.86	0.86	1.11	3.97	1.67	0.35
Leasehold Improvements	30.95	30.95	32.49	32.47	32.93	27.98

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q